QuickView for GYS1;jsessionid=D1696CCCFC29BFDE8968F7D1430B7093 (gene)

1. Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
2. Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora D…
3. The structural mechanism of human glycogen synthesis by the GYS1-GYG1 complex.
4. Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease.
5. MK8617 inhibits M1 macrophage polarization and inflammation via the HIF-1α/GYS1/UDPG/P2Y14 pathway.

There were no clinical trials for GYS1;jsessionid=D1696CCCFC29BFDE8968F7D1430B7093